﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>2</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2013</Year>
        <Month>09</Month>
        <DAY>10</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Cisplatin and renal injury; current concepts</ArticleTitle>
    <FirstPage>89</FirstPage>
    <LastPage>90</LastPage>
    <ELocationID EIdType="doi">10.12861/jrip.2013.28</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Nasri</LastName>
      </Author>
    </AuthorList>
    <PublicationType>EDITORIAL</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.12861/jrip.2013.28</ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>Implication for health policy/practice/research/medical educationCisplatin gives side-effects such as kidney injury which is dose-dependent, limited its use.In recent years much attention has been directed toward the gender difference in cisplatin kidney damage. Indeed, there are sharp sex-dependent differences in reaction rates and the probability of side effects in individuals treated with chemotherapy. Howeverinvestigations regarding sex difference in cisplatin kidney damage is scares and more needs needs to find the clinical significance of gender on renal failure induced by cisplatin.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cisplatin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Renal failure</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Nephrotoxicity</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>